RecruitingNot ApplicableNCT06393231

Clinical Study on the End Time of Acupuncture and Moxibustion Therapy for Peripheral Facial Paralysis

Clinical Study on the End Time of Acupuncture and Moxibustion Therapy for Peripheral Facial Paralysis: Randomized Controlled Trial


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

120 participants

Start Date

May 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Bell's palsy itself has a certain self-healing tendency. Therefore, it is recommended to leave a bit of Bell's palsy for self-recovery without treatment. If complete recovery is achieved after treatment, complications such as stiffness, contracture and even hemifacial inversion may occur as time moves. Therefore, this study aims to evaluate the optimal end time of acupuncture for facial paralysis.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria4

  • Male or female patients aged 18-75 years.
  • Patients diagnosed with peripheral facial paralysis≤7 days before screening and was the first time.
  • All cases have symptoms and signs or have been examined by CT, MRI, etc., excluding peripheral facial paralysis caused by central nervous system diseases, ear diseases, and trauma.
  • Those who voluntarily sign the Research Informed Consent Form

Exclusion Criteria4

  • Patients with bilateral facial nerve palsy or recurrent facial nerve palsy (more than two occurrences).
  • Pregnant or nursing patients.
  • Patients with critically ill which is difficult to make a definite evaluation of the efficacy and safety of treatment
  • Those who accept other treatment methods or cannot adhere to this plan, which affects the efficacy observation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERacupuncture

Acupuncture is applied to ST8, GB14, BL12, SJ23, ST2, SI18, ST4, ST7, RN24, Ex-HN16, SJ17 and LI4 on the affected side and needles are retained for half an hour.Add infrared irradiation therapy in the same time


Locations(1)

Nanjing First Hospital

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06393231


Related Trials